nandrolone has been researched along with verapamil in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, K; Stiefl, N | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Reinach, P; Socci, R; Steinsapir, J | 1 |
| Chorich, LP; Mahesh, VB; Simone, DA | 1 |
| Glusa, E; Gräser, T; Oettel, M; Wagner, S | 1 |
6 other study(ies) available for nandrolone and verapamil
| Article | Year |
|---|---|
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
Topics: Acetates; Alcohols; Algorithms; Cholinergic Agents; Hydrocarbons, Acyclic; Hydrocarbons, Aromatic; Ketones; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship; Receptor, Muscarinic M2; Receptors, Muscarinic; Steroids; Transcortin | 2003 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Effects of androgen on intracellular calcium of LNCaP cells.
Topics: Calcium; Cell Line; Dihydrotestosterone; Fura-2; Humans; Kinetics; Male; Nandrolone; Prostatic Neoplasms; Spectrometry, Fluorescence; Testosterone Congeners; Time Factors; Verapamil | 1991 |
Mechanisms of action for an androgen-mediated autoregulatory process in rat thecal-interstitial cells.
Topics: Androgens; Animals; Calcimycin; Calcium; Cholesterol Side-Chain Cleavage Enzyme; Chorionic Gonadotropin; Female; Homeostasis; Nandrolone; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Steroid 17-alpha-Hydroxylase; Tetradecanoylphorbol Acetate; Theca Cells; Verapamil | 1993 |
Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins.
Topics: Animals; Aorta, Thoracic; Chlormadinone Acetate; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; Hormone Antagonists; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nandrolone; Norethindrone; Phenylephrine; Progesterone; Progesterone Congeners; Rats; Rats, Wistar; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1997 |